DiveRadGel Overview

  • Year Founded
  • 2024

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Seed

  • Investors
  • 3

DiveRadGel General Information

Description

Developer of cancer immunotherapy designed to provide therapies to patients suffering from the disease. The company offers drug delivery, immune activation, and safety that encapsulate large amounts of APIs and enhance solubility to maximize therapeutic efficacy, enabling cancer patients to access drug delivery to lymph nodes and direct uptake by antigen-presenting cells, which dramatically improves cancer immunotherapy outcomes.

Contact Information

Website
diveradgel.co.jp
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 2nd Floor, Sagami Building
  • 7-13-6 Ginza, Chuo-ku
  • Tokyo, 104-0061
  • Japan
Primary Industry
Drug Discovery
Other Industries
Drug Delivery
Biotechnology
Vertical(s)
LOHAS & Wellness, Life Sciences, Oncology
Corporate Office
  • 2nd Floor, Sagami Building
  • 7-13-6 Ginza, Chuo-ku
  • Tokyo, 104-0061
  • Japan

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

DiveRadGel Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Seed Round 24-Aug-2026 Completed Generating Revenue
1. Accelerator/Incubator 08-May-2025 Completed Generating Revenue
To view DiveRadGel’s complete valuation and funding history, request access »

DiveRadGel Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds
ANRI Venture Capital Minority
TOHOKU University Venture Partners Venture Capital Minority
LINK-J Accelerator/Incubator
To view DiveRadGel’s complete investors history, request access »

Ready to get started?

Request a free trial

DiveRadGel FAQs

  • When was DiveRadGel founded?

    DiveRadGel was founded in 2024.

  • Where is DiveRadGel headquartered?

    DiveRadGel is headquartered in Tokyo, Japan.

  • What industry is DiveRadGel in?

    DiveRadGel’s primary industry is Drug Discovery.

  • Is DiveRadGel a private or public company?

    DiveRadGel is a Private company.

  • What is DiveRadGel’s current revenue?

    The current revenue for DiveRadGel is .

  • Who are DiveRadGel’s investors?

    ANRI, TOHOKU University Venture Partners, and LINK-J have invested in DiveRadGel.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process